US 11845937
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
granted A61KA61K47/64A61P
Quick answer
US patent 11845937 (RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/64, A61P, A61P21/00